A Kennedy Krieger Institute researcher is playing a role in a major international effort that has yielded a promising ...

When harmful bacteria or other microorganisms invade the body, neutrophils, a type of white blood cell, are one of the first immune cells to respond. They release powerful weapons to trap and kill ...

The US Food and Drug Administration (FDA) has accepted Otsuka Pharmaceutical’s biologics licence application for ...

A new study published in the journal of BMC Nephrology showed that C3 Granulopathy + pregnancy is linked to a higher risk of ...

Farabursen targets miR-17, which researchers have identified as potentially relevant to kidney disease. People with ADPKD have few ... following our recent approvals of treatments for IgAN and C3G,” ...

Current treatment methods for C3 glomerulopathy (C3G) help support kidney function and suppress immune system activity. Emerging therapies interrupt the proteins responsible for disease activity.

Designed in partnership with C3G clinicians and patients ... We are looking forward to extending our partnership with the rare kidney disease community with this second program in a rare kidney ...

Designed in partnership with C3G clinicians and patients ... We are looking forward to extending our partnership with the rare kidney disease community with this second program in a rare kidney ...